Sowa Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-121
Closed -$30K – 89
2020
Q4
$30K Sell
121
-86
-42% -$22.2K 0.02% 156
2020
Q3
$59K Hold
207
– – 0.04% 113
2020
Q2
$55K Hold
207
– – 0.04% 112
2020
Q1
$65K Hold
207
– – 0.06% 98
2019
Q4
$61K Buy
+207
New +$57.4K 0.05% 110

Other funds holding BIIB

Sowa Financial Group's BIIB Position: Q1 2021 in Review

Sowa Financial Group sold out of Biogen (BIIB) in Q1 2021, closing a stake of 121 shares — an estimated $30K sold.

Sowa Financial Group first reported a position in BIIB in Q4 2019 and held it in 5 quarters. The position peaked at $65K in Q1 2020. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Sowa Financial Group reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Sowa Financial Group sold 121 Biogen shares in Q1 2021, an estimated $30K.
  • Sowa Financial Group first reported a position in Biogen in Q4 2019 and held it in 5 quarters.
  • Sowa Financial Group's Biogen position peaked at $65K in Q1 2020.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Sowa Financial Group's 13F filing for Q1 2021, filed 7 Apr 2021.